IP Library Granted Patent US 11,332,516
Granted Patent B2
US 11,332,516 · App. 15/779,391 · Granted May 17, 2022

Antibody purification method

Inventors: Neil Renault (Midlothian, GB); Andrew Gordon Robb (Midlothian, GB); Janine Scott Robb (Newbridge, GB); David Cooper Robson (Midlothian, GB)
Assignee: QBD (QS-IP) LIMITED
C07K16/065C07K16/34C07K2317/21
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,332,516
App. No.
15/779,391
Granted
May 17, 2022
Kind
B2
Abstract

Disclosed are methods by which compounds/molecules capable of binding antigens, for example antibody type compounds/molecules, can be purified, extracted and/or selected. The methods may be used to purify, extract or select a specific type (or types) of binding agent from a mixed composition. The methods may be used to extract or purify specific binding agents from mixed compositions, which compositions comprise other agents capable of binding other antigens. The methods may find particular application as methods for the purification of blood group antigen antibodies.

Claims (15)

1. A method of purifying an antibody with specificity for a certain or specific blood group antigen, said method comprising:

subjecting a red blood cell or red blood cells to an antigen blocking or neutralising process or protocol prior to use, wherein the antigen blocking or neutralising process or protocol blocks or neutralises only those antigens which may bind antibodies which are not to be purified;

contacting blood, a blood product, serum and/or plasma with the red blood cell or red blood cells under conditions which permit binding between unblocked/not neutralised blood group antigen(s) and antibody within the blood, blood product, serum and/or plasma; and

isolating the bound antibody,

wherein the method does not exploit cell membrane fragments or stroma.

2. The method of claim 1 , wherein the method uses one or more red blood cells expressing one or more blood group antigens.

3. The method of claim 1 , wherein the blood, blood product, plasma and/or serum is derived from or provided by a subject intending to donate blood (blood donors) and/or a subject immunised so as to produce antibodies to a specific target.

4. The method of claim 1 , wherein the antibody is a polyclonal antibody.

5. The method of claim 1 , wherein the red blood cell or red blood cells are not conjugated to a support, support substrate or polymer.

6. The method of claim 1 wherein the step of isolating the bound antibody involves dissociating and/or eluting antibodies absorbed or bound to the surfaces of the red blood cell(s).

7. The method of claim 6 , wherein the dissociating and/or eluting procedures include the use of: heat, rapid freeze/thaw, ultrasonic baths, cell lysis, acid based elution/dissociation, cold acid, organic solvents, xylene, chloroform, modified heat/agitation or chloroquine diphosphate.

8. The method of claim 6 , wherein the step of isolating the bound antibody involves contacting antibody/cell complexes with an elution buffer.

9. The method of claim 8 , wherein the elution buffer is formulated to bring about antibody dissociation through acid elution.

10. The method of claim 8 , wherein the elution buffer comprises, consists essentially of or consists of Glycine-HC1 and NaCl.

11. The method of claim 1 , wherein the antigen blocking or neutralising process or protocol uses antibodies as blocking or neutralising agents.

Assignments (3)
SECURITY INTEREST Recorded Feb 17, 2023
From: QUOTIENT HOLDINGS FINANCE COMPANY LIMITED; ALBA BIOSCIENCE LIMITED; QBD (QS IP) LIMITED; QUOTIENT SUISSE SA
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 062735/0051 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2021
From: ROBB, JANINE SCOTT
To: QBD (QS-IP) LIMITED
Reel/Frame 056604/0741 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2021
From: RENAULT, NEIL; ROBB, ANDREW GORDON; ROBSON, DAVID COOPER
To: QBD (QS-IP) LIMITED
Reel/Frame 056604/0912 →
Priority Claims (1)
GB 1520903.4 · Nov 26, 2015 · national
Continuity (1)
Related Publication 20180305442A1 · Oct 25, 2018